You’ll also get a FREE podcast loaded with tips, information & advice on ovarian cancer.
July 14, 2017
Joann Guerilus
In this webinar, Lidia Schapira, MD, Director of the Cancer Survivorship Program at Stanford University, shares her expertise to help you get the most out of your communication with your oncologist. Learn strategies to optimize your meetings with your health care team.
June 20, 2017
Joann Guerilus
Experts Deborah Axelrod, MD, of NYU Langone Perlmutter Cancer Center, and Rachel Bluebond-Langner, MD, of NYU Langone Medical Center, discuss the latest research in autologous breast reconstruction, fat injection, pre-pectoral implants, and oncoplastic surgery.
April 20, 2017
Melissa Sakow
Following diagnosis and treatment for breast cancer, many women experience changes in their sexuality. In this webinar, Madeleine M. Castellanos, MD, a psychiatrist specializing in sex therapy and sexual medicine, addresses the physical, psychological, and relationship issues that often emerge and explores strategies to find happiness and fulfillment.
DCIS: What You Need to Know from bkling.
A diagnosis of DCIS often brings mixed messages. Is this a real breast cancer? What is the meaning of Stage 0? If this is not life threatening, why are the treatments similar to those recommended for an invasive cancer? Deborah Collyar, founder of Patient Advocates in Research, helps us interpret the new findings that will aid you in navigating this diagnosis.
DCIS: What You Need to Know from bkling
A diagnosis of DCIS often brings mixed messages. Is this a real breast cancer? What is the meaning of Stage 0? If this is not life threatening, why are the treatments similar to those recommended for an invasive cancer? Deborah Collyar, founder of Patient Advocates in Research, helps us interpret the new findings that will aid you in navigating this diagnosis.
March 10, 2017
A breast or ovarian cancer diagnosis brings unimaginable changes to a woman's life. Join us for a webinar as Julie Larson, LCSW, helps you reflect upon the psychological impact of this diagnosis. Learn how to develop strategies to face the challenges and emotions of your new normal.
Steffi Osterreich, PhD, and Rachel Jankowitz, MD, of University of Pittsburgh Cancer Institute, join Heather Hillier, breast advocate and co-chair of the first international ILC Symposium, in offering an overview of Invasive Lobular Carcinoma and highlights from the conference, which took place in Pittsburgh in September 2016. The program was presented in collaboration with MBCN.
This video comes to us from Patient Power (published on December 28, 2016). Breast cancer expert Dr. William Gradishar of Robert H. Lurie Comprehensive Cancer Center of Northwestern University discusses the latest news from the San Antonio Breast Cancer Symposium (SABCS) and explains his role in developing and implementing clinical trials for new therapeutic approaches for breast cancer and promising therapies for 2017.
By Melissa Sakow - November 15, 2016
H. Kim Lyerly, M.D., FACS, discusses research in tumor dormancy in breast cancer, including the role of disseminated tumor cells, bone marrow, and the potential for immune responses to control or prevent recurrences. Dr. Lyerly is Director of the Center of Applied Therapeutics at Duke University.
By Melissa Sakow - June 24, 2016
If you missed our webinar "Finding a Clinical Trial That's Right for You" with Elly Cohen, PhD, Program Director of BreastCancerTrials.org, you can watch it now above!
Elly Cohen works closely with breast cancer organizations that promote patient awareness of clinical trials as a routine option for care. In the webinar, Elly walked listeners through the steps involved in finding clinical trials that are specific to their diagnosis.
By Melissa Sakow - January 22, 2016
Whether you missed it or want to review, you can now watch our latest webinar recording, "Persistent and Intermittent Pain After Breast Cancer," by Mei R. Fu, PhD, RN, ACNS-BC, FAAN, Associate Professor College of Nursing NYU.
By Regina Kraft - March 27, 2015
Dr. Cliff Hudis discusses the latest information on new breast cancer treatments. Dr. Hudis is Chief of Breast Cancer Medicine Service at Memorial Sloan-Kettering Cancer Center.
By Beth Kling - July 30, 2015
If you missed the webinar with Ting-Ting Kuo on Breast-Cancer-Related Lymphedema, listen to the audio here.
By Beth Kling - March 6, 2015
NYU Breast Surgeon Dr. Deborah Axelrod and NYU Cosmetic Surgeon Dr. Jamie Levine discuss the many surgical options available for breast reconstruction. This SHARE Webinar was conducted on March 6, 2015. Skip the first 4 minutes and get right to the doctors; they're a great team!
By Beth Kling - September 25, 2014
If you missed our webinar, "The Cost of the Cure: Collateral Damage from Breast Cancer Treatment with Dr. Susan Love," you can watch it now. Dr. Love gives some great information about breast cancer side effects and how they can be managed. And she talks about how important it is to document side effects so that we can understand the true cost of breast cancer treatments.
(advance to around 2:00 to skip the instructions for participating in the live webinar)
By Beth Kling - June 16, 2014
If you missed SHARE Talk Radio's first show, listen here. Our guest was Fran Visco, President of the National Breast Cancer Coalition. She discussed what's happening with the Breast Cancer Deadline 2020.
September 14, 2017
Joann Guerilus
Caroline L. Bersak, Esq., from The Family Center's Legal Wellness Institute, explores your options for disability insurance in this webinar. Learn about Social Security Disability Insurance, Supplemental Security Income, and special rules and processes for people with metastatic breast cancer.
July 14, 2017
Joann Guerilus
In this webinar, Lidia Schapira, MD, Director of the Cancer Survivorship Program at Stanford University, shares her expertise to help you get the most out of your communication with your oncologist. Learn strategies to optimize your meetings with your health care team.
July 3, 2017
Joann Guerilus
Courtney Hudson, CEO and Co-Founder of EmergingMed, joins us in this webinar to explain the latest clinical trials for metastatic breast cancer and how to find them. Learn how to identify appropriate clinical trials, determine eligibility and "must ask" questions for the researchers, find strategies to determine your best options, and figure out which questions to ask when making your decisions.
June 26, 2017
Joann Guerilus
In this webinar, Dr. Anne Moore, Medical Director of the Weill Cornell Breast Center, joins us to share her experiences from the American Society of Clinical Oncology's June 2017 Conference. She also updates us on the latest research from the conference as it relates to metastatic breast cancer.
By Beth Kling - October 19, 2016
Sylvia Adams, MD, medical oncologist, and associate professor at the NYU School of Medicine, will discuss the latest research including the role of immunology in the treatment of triple negative metastatic breast cancer. This webinar was hosted on October 19, 2016.
By Beth Kling - October 13, 2016
Hear the recording and see the slides from this special webinar hosted on Metastatic Breast Cancer Awareness Day, October 13, 2016.
By Beth Kling - June 29, 2016
Dr. Maura Dickler, a board-certified medical oncologist at MSKCC will present news from the annual meeting of the American Society of Clinical Oncology (ASCO) as it relates to those living with metastatic breast cancer. Q&A period will follow. In collaboration with the Metastatic Breast Cancer Network.
By Melissa Sakow - March 1, 2016
In case you missed it, here's the recording of Dr. Tiffany Traina's highly-rated webinar presenting the latest research on metastatic breast cancer reported at the San Antonio Breast Cancer Symposium in December 2015. A Q&A followed. Dr. Traina is a medical oncologist at Memorial Sloan-Kettering Cancer Center.
By Beth Kling - June 15, 2015
Dr. Clifford Hudis of Memorial Sloan-Kettering Cancer Center (MSKCC) discusses recent developments in the treatment of metastatic breast cancer at a June 2015 gathering co-sponsored by SHARE, MSKCC, and the Metastatic Breast Cancer Network. If you missed his talk, listen here (he starts speaking after a 90-second introduction):
By Christine Benjamin - October 29, 2013
If you missed our webinar, "Managing Symptoms and Side Effects: How Caregivers Can Help," check out the video here. It starts a few slides in, but you'll get really valuable information anyway. The focus is on women with metastatic breast cancer.
By Beth Kling - October 16, 2014
Yesterday's webinar with Dr. Patricia Steeg related her approach to metastatic breast cancer research and talked about the development of experimental models of brain metastasis. If you didn't catch it live, you can watch the video above.
By Beth Kling - October 10, 2014
In last Monday's webinar, Dr. Don Dizon talked about "Coping with October." Those living with Metastatic Breast Cancer often struggle with additional negative feelings during Breast Cancer Awareness Month. Dr. Dizon speaks to women with MBC to offer encouragement and coping strategies specifically tailored for October-related issues. A video of this webinar is now available for you to watch here.
Dr. Matthew Ellis, Baylor College of Medicine, Houston, TX, provides a review of the research presented at SABCS 2016 specifically for MBC. This webinar is in collaboration with MBCN and Theresa's Research Foundation.
4:36 Dr. Matthew Ellis’s thoughts about Metastatic breast cancer
5:57 Breast cancer is caused by mutations (as we get older our cell DNA ages and mutations, or corruptions in the DNA, occur, and they can lead to cancer)
10: 11 “Landscape of somatic mutations in 560 breast cancer whole genome sequences” (scientific paper that attempts to document all the genetic variation in breast cancer across the 3 billion base pairs that makes up the human genome)
12:20 New drugs introduced into treatment of metastatic breast cancer in last year (drugs that target cell enzyme called Cyclin Dependent Kinase: Palbociclib, Abemaciclib, Ribociclib for er+ breast cancer)
14:04 Paloma-2 Trial (Palbociclib)
16:31 MonaLeesa-2 Trial (Ribociclib)
17:39 Belle-3 Trial (Buparlisib; PIK3CA; only works effectively when PI3 Kinase mutation is present. Drugs in this pathway could be helpful for patients with metastatic disease and similar drugs with fewer side effects are in clinical trials.)
19:15 New ways to define therapeutic targets
“Proteogenomics connects somatic mutations to signalling in breast cancer” (scientific paper)
21:40 Can we make the diagnosis of breast cancer mutations easier? (Need for tissue biopsies is difficult because metastatic disease is buried in organs.)
22:36 Cell free plasma tumor DNA in breast oncology: DNA circulates in the blood stream and gene sequences from a tumor can be identified through a simple blood test without the need for a tissue biopsy. (Digital PCR)
23:36 New studies in metastatic disease: ESR1 activating mutations cluster in the LBD
24:32 Falcon Study (Fulvestrant vs. anastrozole)
25:44 Can we harness the immune system to treat breast cancer?
26:17 Breast cancer immunotherapy: Building on clinical success (scientific paper)
26:26 Targeting the PD-1 Pathway in Breast Cancer
28:31 Breast Cancer Can Induce Adaptive Immune Responses
29:07 PD-1/PD-L1 Blockade in Breast Cancer
30:08 Conclusions
30:39 Can we involve more patients in metastatic breast cancer research? (MBC Project, mbcproject.org; challenges of studying patient tumor samples; patient-reported data)
Q&A
36:23 Q&A: Which is the most promising research development for metastatic breast cancer announced at San Antonio Breast Cancer Symposium?
37:30 Q&A: Was anything presented about metastatic triple negative breast cancer other than immunotherapy at the San Antonio Breast Cancer Symposium?
39:21 Q&A: You mentioned cures for metastatic HER 2 positive breast cancer. Can you categorize the nature of the cure?
40:37 Q&A: In the slide you included about circulating cell-free DNA, were you referring to liquid biopsy? Is liquid biopsy being used in practice and are all liquid biopsies created equal?
44:18 Q&A: Is there research into whether drug holidays may help resistance?
45:51 Q&A: When is the best time to do genomic sequencing? Is genomic sequencing generally covered by insurance or Medicare?
49:20 Q&A: How can patients be connected to the clinical research community independent of big institutions?
53:20 Q&A: Was there anything reported about lobular metastatic breast cancer at the San Antonio Breast Cancer Symposium?
56:22 Q&A: A recent scientific article mentioned that mutations vary by the sites being biopsied. How do we decide which sites to biopsy?
57:49 Q&A: Can a drug or chemotherapy regimen that was used successfully and then failed be used again at a later date and be successful?
59:18 Q&A: Any diet recommendations?
SHARE Senior Director of Programs Ivis Febus-Sampayo on Novartis Drug for Metastatic Breast Cancer.
July 14, 2017
Joann Guerilus
In this webinar, Lidia Schapira, MD, Director of the Cancer Survivorship Program at Stanford University, shares her expertise to help you get the most out of your communication with your oncologist. Learn strategies to optimize your meetings with your health care team.
June 23, 2017
Joann Guerilus
In this webinar, Dr. Maurie Markman, President of Science and Medicine at Cancer Treatment Centers of America, joins us to share his expertise on the latest developments in immunotherapy for ovarian cancer.
If you were unable to attend our webinar, you can now view the recording below! This program focused on the latest research in chemotherapy, surgery and clinical trials in the management of recurrent ovarian cancer. Our speaker was Dr. Roisin E. O'Cearbhaill, Memorial Sloan Kettering Cancer Center.
Led by former Program Director, Linda Koteen, and including pictures of survivors from all over the country, five SHARE participants talk about their personal experiences as ovarian cancer survivors, each focusing on one aspect of their experience. They are, in order of presentation, Lorraine Bajada, Diagnosis; Carmen Diaz, Side Effects; Joan Sommer, Recurrence; Annie Ellis, Hope; and Judith Gordon, End of Life. From the 2008 Society of Gynecologic Oncology Annual Meeting in Tampa, Florida
By Beth Kling - June 3, 2014
Annie Ellis, ovarian cancer survivor and research advocate, gave a great presentation last week about research presented at the annual meeting of the American Association of Cancer Research (AACR). If you missed it, you can hear it now and see the slides below.
By Beth Kling - April 15, 2015
Did you miss SHARE's program last week: Ovarian Cancer, What's New? Dr. Stephanie Blank discussed the latest developments in ovarian cancer research and treatment as reported at the Society of Gynecologic Oncology (SGO). Dr. Blank is a gynecologic oncologist at NYU Clinical Cancer Center and an associate professor at NYU School of Medicine.
By Beth Kling - June 17, 2015
If you missed Dr. Kevin Holcomb's talk on Ethnic Disparities in Gynecologic Cancer, watch it here. Dr. Holcomb is Associate Attending Obstetrician and Gynecologist at NY Presbyterian Hospital and Associate Professor of Clinical Obstetrics and Gynecology, Weill Cornell Medical College.
By Beth Kling - October 1, 2015
If you weren't able to attend SHARE's first Annual Joan Sommer Educational Program, "Strategies for Long-term Management of Recurrent Ovarian Cancer,"
Ovarian cancer survivor and advocate Annie Ellis discusses how she manages recurrent ovarian cancer. She spoke at SHARE's 2015 program, "Strategies for Long-Term Management of Recurrent Ovarian Cancer."
By Melissa Sakow - April 29, 2016
If you were unable to make our webinar on the latest updates in ovarian cancer research, you can view it now here!
Dr. Stephanie Blank and Dr. Melissa Frey updated us on the latest developments in ovarian cancer research and treatment from the annual conference of the Society of Gynecologic Oncology. Dr. Blank is a gynecologic oncologist at Perlmutter Cancer Center at NYU Langone Medical Center and an associate professor at NYU School of Medicine. Dr. Frey is a Gynecological Oncology Fellow at NYU Langone Medical Center.
By Melissa Sakow - May 24, 2016
In case you missed Dr. Kevin Holcomb's presentation on CA-125, you can now view it here!
Women who are suspected of having ovarian cancer and women who have been diagnosed with ovarian cancer often receive a blood test to measure their CA-125 level. In the webinar recording below, Dr. Kevin Holcomb, Associate Attending Obstetrician and Gynecologist, NY Presbyterian Hospital, Associate Professor of Clinical Obstetrics and Gynecology, Weill Cornell Medical College, discusses what this test means for diagnosis and clinical management of ovarian cancer.
February 9, 2017
Courtney Hudson, CEO & Co-Founder of EmergingMed, explains the basics of clinical trials and the process of developing new treatments in the emerging age of personalized medicine and immunotherapy. Lean how to identify appropriate clinical trials, find strategies to determine your best options, and figure out which questions to ask when making your decisions.
February 9, 2017
Courtney Hudson, CEO & Co-Founder of EmergingMed, explains the basics of clinical trials and the process of developing new treatments in the emerging age of personalized medicine and immunotherapy. Lean how to identify appropriate clinical trials, find strategies to determine your best options, and figure out which questions to ask when making your decisions.
March 10, 2017
A breast or ovarian cancer diagnosis brings unimaginable changes to a woman's life. Join us for a webinar as Julie Larson, LCSW, helps you reflect upon the psychological impact of this diagnosis. Learn how to develop strategies to face the challenges and emotions of your new normal.
